Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 4

2(25.0%)

Phase 2

1(12.5%)

8Total

N/A(5)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03983408Not ApplicableUnknown

Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease

Role: collaborator

NCT01616134Not ApplicableCompleted

Effect of Korean Red Ginseng on Insulin Sensitivity in Non Diabetic Overweight Korean Adults

Role: lead

NCT01496248Not ApplicableCompleted

Efficacy Study of Korean Red Ginseng to Treat Depression

Role: collaborator

NCT02211352Phase 2Completed

Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension

Role: collaborator

NCT01664156Phase 4Completed

Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet

Role: lead

NCT02034136Not ApplicableUnknown

Ginsenoside Improve Metabolic Syndrome

Role: collaborator

NCT00976274Not ApplicableCompleted

Korean Red Ginseng and Metabolic Syndrome

Role: lead

NCT00911768Phase 4Completed

Effect of Korean Red Ginseng (KRG) on Dry Mouth

Role: lead

All 8 trials loaded